According to Rutgers reports, a "new" drug was developed to treat an unrelated blood disorder, thalassaemia has shown the potential to treat HIV. It's called deferiprone. Its original job is now obselete as researchers stumbled upon its ability to fight HIV DNA in 1998. Unlike the medication that is normally administered to HIV patients, deferiprone aims directly at killing the cells, while the current medication limits the replication of HIV cells. Two differenet things folks. In essence, these antiretrovirals suck.
They are still the effectiveness of the drug, studying a select group of HIV patients in South Africa. Once more information is released, we will keep you all posted.